Tempus Labs Inc is a tech corporation that has developed the Tempus Platform. This platform consists of a tech system designed to liberate healthcare data from confinement and an operating system to render the newly freed data beneficial. Its Intelligent Diagnostics employ AI, specifically generative AI, to enhance the precision, customization, and personalization of laboratory tests.
Baillie Gifford, National Institutes of Health, Ares Management, Revolution Group, Novo Holdings, Lightbank, Kinship Trust Company, T. Rowe Price, Revolution (Washington DC), Alphabet, Kilmahew Ventures, Franklin Templeton, Franklin Venture Partners, Eric Lefkofsky, Illinois Growth and Innovation Fund, Ares Capital Corporation BDC.